Measurements of desmosine and isodesmosine by mass spectrometry in COPD.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 17494786)

Published in Chest on May 01, 2007

Authors

Shuren Ma1, Yong Y Lin, Gerard M Turino

Author Affiliations

1: St. Luke's-Roosevelt Hospital, Department of Medicine, 1000 Tenth Avenue, Mara Center, New York, NY 10019, USA.

Articles citing this

The effect of secondhand smoke exposure on markers of elastin degradation. Chest (2011) 1.41

Methods in elastic tissue biology: elastin isolation and purification. Methods (2008) 1.24

Clinical validity of plasma and urinary desmosine as biomarkers for chronic obstructive pulmonary disease. Thorax (2012) 0.86

Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis. Chest (2009) 0.86

Urinary desmosine: a biomarker of structural lung injury during CF pulmonary exacerbation. Pediatr Pulmonol (2012) 0.82

Liberation of desmosine and isodesmosine as amino acids from insoluble elastin by elastolytic proteases. Biochem Biophys Res Commun (2011) 0.81

The effect of tiotropium therapy on markers of elastin degradation in COPD. Respir Res (2009) 0.79

The VICI-trial: high frequency oscillation versus conventional mechanical ventilation in newborns with congenital diaphragmatic hernia: an international multicentre randomized controlled trial. BMC Pediatr (2011) 0.78

High-sensitivity nanoLC-MS/MS analysis of urinary desmosine and isodesmosine. Anal Chem (2009) 0.78

The Ratio of Free to Bound Desmosine and Isodesmosine May Reflect Emphysematous Changes in COPD. Lung (2015) 0.77

Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs. Biomark Insights (2016) 0.76

Cation exchange HPLC analysis of desmosines in elastin hydrolysates. Anal Bioanal Chem (2011) 0.75

The Pattern of Elastic Fiber Breakdown in Bleomycin-Induced Pulmonary Fibrosis May Reflect Microarchitectural Changes. Lung (2016) 0.75

Articles by these authors

An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29

Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med (2009) 1.70

The effect of secondhand smoke exposure on markers of elastin degradation. Chest (2011) 1.41

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency. Thorax (2007) 1.12

Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Chest (2003) 1.09

The detection and quantitation of free desmosine and isodesmosine in human urine and their peptide-bound forms in sputum. Proc Natl Acad Sci U S A (2003) 1.00

Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2011) 0.93

Can exogenously administered hyaluronan improve respiratory function in patients with pulmonary emphysema? Chest (2004) 0.90

Aerosolized hyaluronan limits airspace enlargement in a mouse model of cigarette smoke-induced pulmonary emphysema. Exp Lung Res (2005) 0.89

Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.83

Characterization of peptide fragments from lung elastin degradation in chronic obstructive pulmonary disease. Exp Lung Res (2010) 0.83

Therapeutic effects of hyaluronan on smoke-induced elastic fiber injury: does delayed treatment affect efficacy? Lung (2010) 0.83

Association of cigarette smoking and CRP levels with DNA methylation in α-1 antitrypsin deficiency. Epigenetics (2012) 0.81

The effect of tiotropium therapy on markers of elastin degradation in COPD. Respir Res (2009) 0.79

Elastin degradation: an effective biomarker in COPD. COPD (2012) 0.78

Alpha-1 antitrypsin augmentation therapy and biomarkers of elastin degradation. COPD (2013) 0.78

COPD and biomarkers: the search goes on. Thorax (2008) 0.78

Therapeutic gains of prolonged bronchial dilatation in chronic obstructive pulmonary disease. Ann Intern Med (2005) 0.77

Proteases in COPD: a critical pathway to injury. Chest (2007) 0.76

Desmosine and Isodesmosine as a Novel Biomarker for Pulmonary Arterial Hypertension: A Pilot Study. Am J Ther (2015) 0.76

Synergistic effect of hydrogen peroxide and elastase on elastic fiber injury in vitro. Exp Biol Med (Maywood) (2006) 0.75

The effect of lysozyme on elastase-mediated injury. Exp Biol Med (Maywood) (2002) 0.75

Alpha1-antitrypsin deficiency: lessons from longevity. Chest (2009) 0.75

Stable deuterium internal standard for the isotope-dilution LC-MS/MS analysis of elastin degradation. Anal Biochem (2013) 0.75

Total synthesis of COPD biomarker desmosine that crosslinks elastin. Chem Commun (Camb) (2012) 0.75

Synthesis and LC-MS/MS analysis of desmosine-CH2, a potential internal standard for the degraded elastin biomarker desmosine. Org Biomol Chem (2014) 0.75